6 Dimensions' imuno-oncology play Curon raises $150M series A

Curon Biopharmaceutical Ltd. (Shanghai, China) raised $150 million on July 27 in a series A round from 6 Dimensions Capital, Boyu Capital and Temasek.

Curon will use the funds to expand its pipeline of next-generation immunotherapeutic cancer agents. 6 Dimensions, which incubated the biotech, did not respond to inquiries regarding the financing round or Curon's pipeline...